Cefazolin Pharmacokinetics in Premature Infants

OBJECTIVE: Pharmacokinetic (PK) data to guide cefazolin dosing in premature infants is virtually non-existent. Therefore, we aimed to characterize cefazolin PK in infants aged ≤32 weeks of gestation at birth. STUDY DESIGN: We conducted a prospective, open-label PK and safety study of cefazolin in in...

詳細記述

保存先:
書誌詳細
出版年:J Perinatol
主要な著者: Balevic, Stephen J., Smith, P. Brian, Testoni, Daniela, Wu, Huali, Brouwer, Kim L.R., Zimmerman, Kanecia O., Rivera-Chaparro, Nazario D., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713589/
https://ncbi.nlm.nih.gov/pubmed/30944398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41372-019-0368-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料